Announcement on Adjusting Guarantee Amount among Subsidiaries and Providing Guarantee for Subsidiaries
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Adjusting Guarantee Amount among Subsidiaries and Providing Guarantee for Subsidiaries
Filed with SSE · · 6 pages · Chinese
Release
Henan Taloph Pharmaceutical Stock Co. Ltd. on 6ix
Earlier from Henan Taloph Pharmaceutical Stock
- Announcement on Progress in Providing Guarantee for Financing of Subordinated Holding Subsidiary
- Announcement on Change of "Drug Manufacturing License"
- Announcement on Implementation of Dividend Distribution for Q1-Q3 2025
- Announcement on Using Idle Self-owned Funds for Entrusted Wealth Management
- Plan for Issuing A-shares to Specific Objects in 2025
Later from Henan Taloph Pharmaceutical Stock
- Announcement on Progress in Receiving the "Decision on No Further Review of the Anti-Monopoly Examination for Concentration of Undertakings" and Proposed Change of Controlling Shareholder and Actual Controller
- Announcement on Results of Issuing Phase I Ultra-Short-Term Financing Bonds of 2026
- Announcement on Completion of Redemption of the Phase I Ultra-short-term Financing Bonds for 2025
- Announcement on Progress in Adjusting Guarantee Amount among Subsidiaries and Providing Guarantee for Subsidiaries
- Announcement on 2025 Annual Profit Distribution Plan
Follow Henan Taloph Pharmaceutical Stock into a list and get an email when it puts out news.
Follow Henan Taloph Pharmaceutical Stock